PHOENIX - September 18, 2020 - (Newswire.com)
Alaxo Airway Stents announces Dr. Mark A. D'Agostino joins Alaxo as Chief Medical Advisor.
Alaxo Airway Stents (Alaxo) is pleased to announce that Dr. Mark D'Agostino has joined Alaxo as Chief Medical Advisor, effective immediately.
"We are excited to welcome Dr. D'Agostino as Alaxo's new Chief Medical Advisor," said Terry Bayliss, CEO of Alaxo. As a founding member of the International Society of Sleep Surgeons, and a member of the American Academy of Sleep Medicine Dr. D'Agostino brings a wealth and knowledge and experience to Alaxo."
Dr. D'Agostino states, "I am looking forward to working with Alaxo as Chief Medical Advisor. Nasal obstruction can cause or contribute to snoring, obstructive sleep apnea, headaches, halitosis, poor dental health and have ill effects on metabolism. Alaxo provides a simple non-surgical cure for nasal obstruction. A clear nasal airway leads to improved mental and physical health, athletic performance and better sleep."
About Dr. D'Agostino
Dr. D'Agostino is originally from North Haven, CT. He obtained his M.D. degree in 1989 from the Chicago Medical School. In 1994 Dr. D'Agostino completed his internship and residency at the McGaw Medical Center, Northwestern University, Chicago, Ill., He then went on to practice as an active duty physician with the United States Air Force at Malcolm Grow Medical Center at Andrews A.F.B. in Maryland. While at Malcolm Grow Medical Center, Dr. D'Agostino served as a consultant to the Pentagon, the Military Bands and Lajes A.F.B. Terciera, Azores. He started a voice clinic, a snoring and sleep apnea clinic for the active duty and retired military personnel in the Washington, D.C. area. He received a Commendation Medal and in 1997 left the Air Force as a Major.
Since 1995, Dr. D'Agostino is board certified from the American Board of Otolaryngology and from the American Board of Sleep Medicine since 2010. He is a Fellow of the American Academy of Otolaryngology/Head and Neck Surgery and the American College of Surgeons. He is a founding member of the International Society of Sleep Surgeons, and a member of the American Academy of Sleep Medicine, New Haven County Medical Society, Connecticut State Medical Society, and the Connecticut ENT Society. Dr. D'Agostino is on staff at four hospitals (Middlesex, Midstate, Griffin and Yale) and is the Section Chief at Middlesex Hospital.
Alaxo Airway Stents (Alaxo) offers FDA and Health Canada registered, internationally patented, innovative stent-based therapies to support healthy, natural, nasal breathing solutions for snoring, sleep apnea and enhanced athletic performance.
Made of nitinol, a nickel-titanium alloy that has super-elastic characteristics, our innovative stents support the upper airway passage to allow for better airflow and easier breathing.
The Alaxo product line is clinically proven to improve nasal breathing, improve sleep and enhance athletic performance. The AlaxoStent is clinically tested and bears the CE Mark for treatment of patients with obstructive sleep apnea or snoring.
Company Website www.alaxousa.com
Contact us at Info@alaxousa.com
We Seek Safe Harbor
Press Release Service by Newswire.com
Original Source: Alaxo Airway Stents Announces Dr. Mark A. D'Agostino Joins as Chief Medical Advisor